Tellzy-CH 6.25 Tablet
Marketer
Alembic Pharmaceuticals Ltd
Salt Composition
Telmisartan (40mg) + Chlorthalidone (6.25mg)
Overview Tellzy-CH 6.25 Tablet
Hypertil-CH 6.25 tablets combine two active ingredients to effectively manage hypertension. This dual action reduces the long-term risk of stroke and heart attack. Hypertil-CH 6.25 can be taken with or without food; dosage is personalized based on individual response and medical history. Consistent daily dosing is crucial. Continue treatment as directed by your physician; discontinuation may increase cardiovascular risk. The formulation includes a diuretic, promoting increased urination, so avoid ingestion within four hours of bedtime. Regular use, even during periods of well-being, is essential for optimal effect, as hypertension often lacks noticeable symptoms. Dizziness is a common side effect; others include nausea, diarrhea, headache, and lipid profile changes. Increased urination is an intended effect of the chlorthalidone component and contributes to blood pressure control. While rarer side effects are possible, consult the accompanying patient information leaflet. Report any persistent or bothersome side effects to your doctor; dosage adjustments or alternative therapies may be considered. This medication is contraindicated during pregnancy and should be used with caution in patients with kidney or liver disease, cardiac issues, or diabetes. Alcohol consumption may exacerbate hypotension and increase the risk of adverse effects.
Uses of Tellzy-CH 6.25 Tablet
Elevated blood pressure
Major Benefits of Tellzy-CH 6.25 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Tellzy-CH 6.25 Tablets. Ingest the tablets whole; do not chew, crush, or divide them. These tablets can be taken with or without food, however, consistency in timing is recommended.
Common Side effects of Tellzy-CH 6.25 Tablet:
- Dizziness
- Back pain
- Sinus infection
- Diarrhea
- Red spots or bumps
- Decreased potassium level in blood
- Increased uric acid level in blood
- Postural hypertension (high blood pressure)
- Impotence
- Loss of appetite
- Gastrointestinal disturbance
How to use Tellzy-CH 6.25 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Tellzy-CH 6.25 Tablets. Ingest the tablet whole; avoid chewing, crushing, or breaking it. These tablets can be taken with or without food, however, consistent timing is recommended.
How Tellzy-CH 6.25 Tablet works:
Tellzy-CH 6.25mg tablets contain a dual-drug formulation.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Tellzy-CH 6.25 Tablet is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Using Tellzy-CH 6.25 Tablet during pregnancy is strongly discouraged due to established risks to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingUNSAFE
Lactation and Tellzy-CH 6.25 tablets are incompatible; the medication poses a potential risk of infant toxicity.
DrivingUNSAFE
Using Tellzy-CH 6.25 Tablets might reduce alertness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with severe kidney impairment should use Tellzy-CH 6.25 mg tablets cautiously, potentially requiring dosage modification under medical supervision. This medication is generally not advised for such individuals.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Tellzy-CH 6.25 mg tablets, as dose modification may be necessary. Consult your physician for guidance. Tellzy-CH 6.25 mg tablets are contraindicated in individuals with severe liver disease.
What if you forget to take Tellzy-CH 6.25 Tablet :
Should you forget a Tellzy-CH 6.25 Tablet dose, administer it immediately. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Tellzy-CH 6.25 Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |





